Dr Roland Starlinger
Co-Founder and Chief Medical Officer

About

Roland Starlinger, PhD, is Co-Founder and Chief Medical Officer of Oncofuse. With more than 28 years in the pharmaceutical industry, he has served in multiple roles in marketing and sales, portfolio management and medical affairs in local, regional and global functions. He combines a strong scientific foundation with hands-on expertise in Immunology and a deep specialisation in oncology – over 25 years – across both medical and commercial functions.

Contributions

EARLY INSIGHT

SCALING RADIOLIGAND THERAPY: WHY PACKAGING AND DELIVERY SYSTEMS MUST EVOLVE

Dr Eva Littringer and Dr Roland Starlinger discuss the exciting new frontier of radioligand therapy and the imminent bottleneck presented by current delivery methods running into strict limits on handling radioactive materials. They go on to introduce the Oncofuse prefilled-syringe-based system as a novel approach to containment and handling of these therapies, enabling radioligand therapy to expand beyond niche specialist clinics and hospitals.